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ABSTRACT  
   
Changes to the microenvironment of the endothelium can produce significant 
changes in the response of endothelial cells to stimuli. Human Aortic Endothelial Cells 
(HAECs) are tested in vitro for their fluid shear stress response when their substrates, and 
the solute concentrations of the fluids to which they are exposed, are modulated, and for 
their nitric oxide expression when they are exposed to hyperglycemic conditions. ImageJ 
is used to quantify either the degree of cellular alignment and elongation with the 
direction of flow, or the relative NO expression using the fluorochrome DAF-2. First, the 
results of Brower, et.al. are replicated: HAECs under normal glucose (4mM) conditions 
align and elongate with flow (p<<0.05), while high glucose (30.5mM) conditions negate 
this effect (p<<0.05) and is likely the result of Advanced Glycation End-products 
(AGEs). Then, in this study it is found that substitution of fibronectin for gelatin 
substrates does not impair flow (p<<0.05), indicating that fibronectin likely does not 
participate in the initiation of vascular lesions. High palmitic acid also does not prevent 
HAEC shear response (p<<0.05), which is consistent with Brower’s predictions that 
AGEs are responsible for impaired elongation and alignment. NO production is 
significantly increased (p<<0.025) in HAECs cultured 24 hours under high glucose 
(30.5mM) conditions compared with normal glucose (4mM) conditions, indicating the 
presence of inducible nitric oxide as part of an inflammatory response. Aminoguanidine 
(5mM) added to high glucose concentrations reduces, but does not eliminate NO 
production (p<<0.05), likely due to insufficient concentration. Modulation of the 
endothelial microenvironment leads to pronounced changes in HAEC behavior with 
regards to NO production under hyperglycemic conditions.  Diabetic model rat aortas are 
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explanted and imaged for the purpose of detecting aortic endothelial cell alignment and 
elongation; improvements in this method are discussed. A microvessel chamber used 
with explanted human tissue is re-fit to reduce required volumes of solutions and allow 
more effective experimentation.  
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CHAPTER 1 
INTRODUCTION 
Why Study the Endothelial Microenvironment? 
The vascular endothelium is a thin layer of cells that lines the interior of blood 
vessels and arteries. Its essential functions include forming a selective blood barrier, and 
maintaining vascular homeostasis through its participation in blood clotting, 
angiogenesis, vasoconstriction, vasodilation, and inflammation (Behrendt, 2002). 
However, these functions may be disrupted, or disease states may occur when the 
microenvironment surrounding the endothelium is fundamentally changed, through 
modulations of the basement membrane, or variations in the concentration of 
biomolecular compounds in the blood. Endothelial microenvironmental changes, such as 
hyperglycemia, are often associated with diseases, such as diabetes, whose physiologic 
impact may be partially explained at the cellular level. For this reason, a better 
understanding of how endothelial cells respond to microenvironmental changes may help 
explain the characteristics of certain diseases, and aid in the design of better treatments.  
 An in vitro model of the vascular endothelium is an appropriate means to study 
the function of the endothelial layer because the endothelium exists in tissue in a largely 
two-dimensional environment (Behrendt, 2002). Few cell types found in tissue exist in 
two-dimensional environments, but endothelial cells do: the culture of endothelial cells, 
on protein-coated glass, that are exposed to physiologic shear stress resulting from flow, 
provides an analog to endothelial cells that grow a single layer thick on the luminal 
surface of a vessel carrying blood.  This analog is offered in contrast to the culture of 
most cell types, which takes cells that exist in three-dimensional tissues and causes them 
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to proliferate in two-dimensional spaces, potentially altering any number of their 
behaviors, responses, or phenotypic expressions.  
 
Why Study the Explanted Endothelial Microenvironment?  
 The cost of developing new drug treatments is now estimated at well over $1 
billion USD per successful drug brought to market (Adams, 2010). The tremendous cost 
and time investment in developing new drugs is a result, at least in part, of the vast 
screening and elimination process of new targets, beginning at the cellular level and 
progressing through many stages prior to human clinical trials (Adams, 2010). Once a 
molecular compound has shown promise at the cellular level, it may then be tested in 
animal models such as mice and rats; then tested in a larger animal analog such as a dog 
or pig, and finally in three stages of human clinical trials. Thousands of drugs may be 
identified as targets at the cellular level, but fewer than ten of those targets will show 
safety and efficacy in the animal models and through the process of clinical trials 
(Adams, 2010). It has been speculated that one reason for this sharp narrowing of 
potential candidates is that drug screening at the cellular level does not represent a picture 
of the overall biological system. Moreover, at the animal level, candidate drug 
interactions with animal systems may or may not accurately represent the interactions 
that drug would have with a human system.  
 Recent studies using explanted tissue samples may provide a partial remedy for 
the cost of drug development by allowing researchers to explore drug targets at the tissue 
level, potentially without expensive animal trials (Cahill, 2012). Specifically, our 
collaborators at the Phoenix Veteran’s Affairs hospital have developed a method for 
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obtaining microvessel samples from fat biopsies of enrolled patients. The ability to study 
drug targets using human tissue, without requiring a human clinical trial that may expose 
human subjects to additional risk, could substantially reduce the barriers of time and cost 
in identifying candidates for new treatments.  
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CHAPTER 2 
ENGINEERING THE IN VITRO MICROENVIRONMENT 
Introduction 
The Endothelial Microenvironment and High Glucose Concentrations. Previous 
studies in the Caplan laboratory group have shown that disease states such as 
hyperglycemia can modulate the in vitro response of endothelial cells that are exposed to 
physiologic shear stress (Brower, 2009 and Kelso, 2011). Brower, et. al. showed that 
endothelial cells cultured under high glucose (30.5mM) conditions for 24 hours and then 
subjected to physiologic shear stress (8 dynes / cm2) through fluid flow lose their 
characteristic ability to align and elongate with the direction of flow (2009). The loss of 
this ability may be related to the buildup up of atherosclerotic plaques seen in diabetes; 
briefly, plaques typically accumulate in regions of low shear stress within the vasculature, 
but in diabetics these plaques become disseminated. Lack of tight cell junctions, which 
can develop in flow-aligned endothelial layers, may allow for easier penetration of LDL 
cholesterol (Brower, 2009). That is, physiologic shear stress is atheroprotective, but low 
shear stress (like that seen in the junctions of arteries) is atherogenic, but the 
atheroprotection offered by physiologic shear stress is apparently diminished in diabetics.  
Brower also showed that aminoguanidine, an inhibitor of advanced glycation end 
products, restored the ability of endothelial cells to align and elongate with flow, even 
after culture in high glucose conditions (2009). Kelso, et. al. later showed that pyridoxine, 
which shares key functional groups with aminoguanidine, also restored this cellular 
ability; pyridoxine is metabolized into vitamin B6 in the body (2010). It should be noted 
that Brower and Kelso saw the most pronounced effect on endothelial cellular elongation 
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and alignment when the concentrations of glucose were at the upper end of what is seen 
clinically (30.5 mM is approximately 549 mg / dl).  
To validate the flow approach used in this study, a first aim is to replicate the 
results found by Brower and Kelso with regards to endothelial response to shear in high 
and normal glucose conditions. It is then reasonable to explore other blood solutes that 
may affect endothelial cell response. One of these is palmitic acid, a saturated free fatty 
acid that may be used to simulate the high level of fatty acids associated with vascular 
disease and diabetes; this study will explore the effects of palmitic acid on endothelial 
shear response as another of its aims.  
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Figure 2.1: High Extracellular Glucose Concentrations Impair HAEC Alignment in 
Response to 8 dynes / cm2 Fluid Shear Stress (Brower, 2009). Brower, et. al. show that 
high concentrations of glucose impair the alignment response of Human Aortic 
Endothelial Cells (HAECs) at concentrations greater than 17.5 mM, though the most 
pronounced impairment is seen at 30.5mM. Static cultures show no substantial 
alignment; normal glucose cultures at 5.5 mM placed under shear show a substantial 
degree of elongation (2009).  
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Figure 1 is from the thesis dissertation of Dr Jeremy Benjamin Brower. 
 
The Endothelial Microenvironment and Changes in the Basement Membrane. 
Endothelial cells rest on a layer of extracellular matrix proteins, known as the basement 
membrane, that consists primarily of laminin and collagen IV (Hahn, 2009). However, in 
the lesions of atherosclerotic plaques, the basement membrane has been observed to 
include deposits of fibronectin (Orr, 2005). A recent study has shown that flow-exposed 
cellular signaling of JNK, a kinase involved in the inflammatory response, is upregulated 
in areas of fibronectin deposits and in atheroprone regions, indicating that fibronectin 
may play an important role in the endothelial cell response to flow-induced shear stress 
(Hahn, 2005). Given that fibronectin (Fn) may be associated with atherosclerotic lesions, 
it is hypothesized that cells cultured on fibronectin substrates will show similar 
impairment of endothelial cell shear stress response. One aim of this study is to explore 
this hypothesis.  
Self-Modulating Environment: The Endothelium and Nitric Oxide Expression. 
Endothelial cells play an important role in maintaining vascular homeostasis through 
their secretion of nitric oxide (NO), an important signaling molecule that inhibits the 
proliferation of smooth muscle cells and causes vasodilation (Davignon, 2004). 
Specifically, NO production leads to the synthesis of cyclic GMP (cGMP), which leads to 
muscle relaxation. NO is secreted from endothelial cells when endothelial nitric oxide 
synthetase (eNOS) catalyzes the breakdown of L-arginine to L-citrulline and NO 
(Davignon, 2004). The nitric oxide synthetase family includes at least three members. 
eNOS and its complementary nNOS (which acts on neurons in signal transduction) are 
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both calcium-dependent synthetases that produce comparatively low amounts of NO. 
iNOS, or inducible nitric oxide synthetase, however, produces high levels of NO that may 
exceed 1000-fold those produced by eNOS or nNOS (Feng, 2001 and Beck, 1999).  
iNOS is thought to be produced primarily by macrophages (though other cell types may 
have the ability) as part of a cytotoxic response to kill bacteria, cancer cells, or parasites, 
but high NO concentrations also increase cell apoptosis and have been shown to increase 
mortality in mice (Feng, 2001). NO expression may thus be an important metric of 
cellular behavior under microenvironmental changes, and indeed forms a part of the 
response itself.  
 Detection of nitric oxide expression has been developed using the fluorochrome 
4,5-diaminofluorescein diacetate (DAF-2), which reacts with NO to produce green-
fluorescent triazolofluorescein. DAF-2 is membrane-permeable and can detect NO with a 
sensitivity of up to 5nM; traizolofluorescein is non-permeable and thus remains within 
the cell (Kojima, 1998).  Using the NO-detection capabilities of DAF-2, an objective of 
this study is to determine what NO production differences, if any, are found between cells 
cultured under normal glucose, high glucose, and high glucose + aminoguanidine 
conditions. It is hypothesized that high glucose will result in increased NO production, 
and that aminoguanidine, a known eNOS inhibitor, will cancel this effect (Corbett, 1992).  
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Methods 
Cell Culture. Human Aortic Endothelial Cells (HAECs) are cultured at 37°C and 
5% CO2 in Gibco® Medium 200 (Life Technologies M-200-500) with Low-Serum 
Growth Supplement (Life Technologies S-003-10), and with 1% L-glutamine and 1% 
penicillin/streptomycin. Media is changed every 48 hours. Baseline media glucose 
concentration is 4mM.  
For flow experiments, cells are cultured on glass chamber slides (LabTex® II 
Chamber Slides #177372) that have been treated with gelatin or fibronectin at a density 
of 6.3 mg / cm2 (Brower, 2009). For high glucose cultures, a 1M solution of D-glucose 
(Sigma #D8375) is added to change the culture concentration to 30.5mM. For high 
palmitic acid cultures, bovine serum albumin is added at a concentration of 4mM to 
increase affinity for the palmitic acid and allow endothelial cells to interact with the fatty 
acid. Palmitic acid is added immediately after the bovine serum albumin at a 
concentration of 200µM. All flow cultures are allowed 24 hours of incubation at 
experimental conditions prior to exposure to flow at 80-100% confluence. 
For NO expression experiments, cells are cultured in a 12-well flat-bottom plate 
(BD Falcon #353043) for 24-hours at experimental conditions prior to running the assay 
at 70% confluence.  High glucose cultures are at 30.5mM as described above; high 
glucose + aminoguanidine cultures included a 5mM solution of aminoguanidine 
bicarbonate (Sigma #A7259) in addition to the high glucose.  
Flow Experiments. Cells were subjected to 8.0 dynes / cm2 of shear stress for 12-
hour periods using culture media treated at experimental concentrations, with the addition 
of HEPES Buffer Solution (Life Technologies #15630-106) to 10mM to maintain pH 
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balance. Shear is calculated as τ = 6µQ/h2b, where τ is the shear stress at the chamber 
slide, µ is the fluid viscosity (8.50 × 10-4 Pa s), Q is the volumetric flow rate (5.833 × 10-8 
m3 s-1), h is the flow chamber height (250 × 10-6 m), and b is the flow chamber width (6.0 
× 10-3 m).  A peristaltic pump is used in conjunction with an upstream and downstream 
reservoir that serve as flow dampeners that permit laminar flow. The chamber slide is 
mounted to an Immunetics® flow chamber, held in place by vacuum. Pump, reservoirs, 
flow chamber, and connecting tubing are kept in a 37°C incubator for the duration of the 
experiment.  
Cells are imaged pre-and post-experiment at 10x magnification on a phase 
contrast light microscope. Each cell is analyzed as a separate data point using ImageJ to 
trace cell boundaries and calculate major and minor axes and angle relative to the 
horizontal, from 0 - 180°. For angles greater than 90°, the formula new = 180 – old, 
where “new” is a normalized angle of alignment and “old” is the original measurement 
was applied; this gives all values under 90° relative to flow and allows for comparison to 
a projected random average of 45°. Statistical significance is set at alpha = 0.05 and 
unpaired t-tests (one-tailed) are used to check for cell aspect ratio and cell angle relative 
to flow. A Bonferroni correction is used for increasing replicates. Briefly, a test for 
significance with significance at 0.05 predicts one of twenty replicates will be 
erroneously found to be insignificant. Thus, the p-value should be halved as a Bonferroni 
correction for each additional replicate, to minimize the possibility of erroneous tests for 
significance. When two replicates are conducted in this study, significance is reduced 
from alpha = 0.05 to alpha = 0.025.  Note that the number of replicates is independent of 
sample size.    
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NO Expression Assays. After the 24-hour incubation period in experimental 
conditions, cells are imaged at 10x magnification under phase contrast and FITC 
fluorescence to establish baseline auto-fluorescence. DAF-2 is then added at a 
concentration of 5µM and cells are imaged in both phase contrast and FITC fluorescence. 
Because baseline NO expression is close to the noise floor of the assay, a stimulant is 
added to magnify differences between NO expression in test conditions. This stimulant is 
calcium ionophore A23187 (Sigma #21045 FLUKA). After 10min and 30 min of 
incubation with A23187, cells are imaged in both phase contrast and fluorescence. Using 
the phase contrast images to identify individual cells, the total integrated brightness of 
fluorescence of each cell is measured using ImageJ, and background auto-fluoresence is 
subtracted. A 2-tailed unpaired t-test is used to determine significance of the mean cell 
fluorescence at alpha = 0.05, with a Bonferroni correction employed as described above 
for increasing number of replicates.   
 
Results  
Endothelial Cells Under Physiologic Shear Stress. As previously found by 
Brower, et. al., HAECs cultured on gelatin under normal glucose (4mM) conditions 
responded to physiologic shear stress through cellular alignment and elongation parallel 
to the direction of flow (p<<0.05 for both alignment and elongation). Similarly, HAECs 
cultured under high glucose conditions (30.5mM) failed to align (p=0.826 for a test of 
average angle of orientation is not 45°) and showed reduced elongation in comparison 
with the normal glucose culture (p<<0.05).  
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 HAECs cultured on gelatin under high concentrations of palmitic acid (200µM) 
did not show a response that was statistically different from that of the normal glucose 
culture; that is, these cells both aligned and elongated in the presence of shear (p<<0.05 
for both alignment and elongation greater than that of the high glucose culture).  
 When the culture substrate was changed from gelatin on glass to fibronectin on 
glass, the elongation response of the HAECs was unchanged (p<<0.05), but cellular 
alignment with the direction of flow was reduced relative to the normal glucose on 
gelatin culture (p<<0.05), though alignment and elongation was improved relative to that 
of high glucose on gelatin conditions (p<<0.05).  
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Figure 2.2: Human Aortic Endothelial Cell Alignment and Elongation under 
Physiologic Shear Stress from Flow. HAECs are cultured on gelatin or fibronectin-
treated glass chamber slides in normal glucose (4mM), high glucose (30.5mM) or high 
palmitic acid (200µM) conditions. Cells are subject 8.0 dynes/cm2 of shear stress from 
flow using media containing normal glucose, high glucose, or high palmitic acid 
concentrations. When cultured under normal glucose conditions, HAECs align and 
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elongate with the direction of flow (p<<0.05). High glucose concentrations destroy this 
effect (p=0.826). Changing the substrate of culture from gelatin to fibronectin preserves 
alignment and elongation (p<<0.05). Cells cultured under high palmitic acid conditions 
retain their ability to align and elongate with flow (p<<0.05). Direction of flow is 
indicated. Images are phase contrast at 10x magnification.  
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Figure 2.3: Human Aortic Endothelial Cell Aspect Ratio and Angle of Alignment 
under Physiologic Shear Stress from Flow. In Figure 2.3A (top), the aspect ratio of 
cells grown under a combination of glucose or palmitic acid concentration and substrate 
are shown: normal glucose / gelatin (n=165), high glucose / gelatin (n=138), normal 
glucose / fibronectin (n=134), and high palmitic acid / gelatin (n=98). Bars show mean 
aspect ratio, plus or minus the standard error of the mean. High glucose / gelatin 
treatment of HAECs shows reduced aspect ratio compared with the other three 
treatments. Alignment, but not elongation, is reduced when HAECs are cultured on 
fibronectin and exposed to flow.  In Figure 2.3B (bottom), the mean angle of orientation 
of the HAECs, relative to flow, is shown, plus or minus the standard error of the mean for 
normal glucose / gelatin (n=165), high glucose / gelatin (n=138), normal glucose / 
fibronectin (n=134), and high palmitic acid / gelatin (n=98) conditions. Randomly-
oriented cells are assumed to have an angle of 45° relative to the horizontal (the direction 
of flow); the high glucose / gelatin combination does not vary significantly from this 
random orientation. All other treatments have angles that are significantly different from 
45°, indicating mean cellular alignment with flow.  
Nitric Oxide Expression. Nitric oxide (NO) expression was measured for 
cells grown under normal glucose (4mM), high glucose (30.5 mM) and high glucose + 
aminoguanidine (30.5mM and 5.0mM, respectively) conditions for a 24-hour period, 
using the fluorochrome DAF-2 (4,5-diaminofluorescein diacetate) to selectively bind NO. 
Mean fluorescence per cell was tested for each treatment, with the normal and high 
glucose treatments repeated. High glucose culture conditions resulted in the highest level 
of NO expression by HAECs (p<<0.025), with high glucose + aminoguanidine as the 
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second-highest, statistically different level (p<<0.05), and finally normal glucose 
conditions leading to the least amount of NO expression (p<<0.025).  
 
 
Figure 2.4: Human Aortic Endothelial Cell Nitric Oxide (NO) Expression using 
DAF-2 Fluorescence. HAECs are cultured under normal glucose (4mM), high glucose 
(30.5mM), or high glucose + aminoguanidine (30.5mM and 5mM, respectively) 
conditions for a 24-hour period. NO expression is measured through the fluorescence of 
DAF-2 (4,5-diaminofluorescein diacetate) which fluoresces selectively for NO. HAECs 
grown under normal glucose conditions show the lowest NO expression (p<<0.025). 
High glucose conditions led to the highest level of NO expression by HAECs (p<<0.025). 
High glucose + aminoguanidine conditions produced a moderate level of NO expression 
by HAECs, greater than that of the normal glucose conditions but less than that of the 
high glucose conditions alone (p<<0.05). Top images are captured at 10x magnification 
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using phase contrast microscopy; bottom images are using FITC settings at 10x 
magnification. Contrast of the images in this figure has been enhanced post-analysis. 
 
 
 
 
Figure 2.5: Human Aortic Endothelial Cell Relative NO Expression under High 
Glucose, Normal Glucose, and High Glucose + Aminoguanidine Conditions. In 
*	  
	  	  	  *	  
	  	  	  	  	  **	  
	  18	  
Figure 2.5A (top), the relative fluorescence of HAECs cultured under normal glucose 
(4mM, n=22) and high glucose (30.5mM, n=86) conditions is shown as a mean value per 
cell, with the error bars showing the standard error of the mean. Fluorescence shown is 
relative to the background level of dish auto-fluorescence, and should not be considered a 
meaningful quantification, other than the relative significance of greater NO expression 
of HAECs under high glucose (p<<0.025). In Figure 2.5B (bottom), the relative mean 
fluorescence per cell, plus or minus the standard error of the mean, is shown for a second 
replicate of normal glucose (4mM, n=22) and high glucose (30.5mM, n=35), and a single 
replicate of high glucose + aminoguanidine (30.5 mM and 5mM, respectively, n=140) 
culture conditions. Normal glucose conditions show essentially zero relative 
fluorescence, indicating zero relative NO expression (p<<0.025). High glucose 
conditions led to the greatest relative expression of NO (p<<0.025), while 
aminoguanidine with high glucose reduced the comparative NO expression (p<<0.05) 
relative to the high glucose results, though it was still significantly greater than that of the 
normal glucose conditions alone (p<<0.05).  
 
Discussion 
The experimental approach for the flow system was validated in the replication of 
the results of Brower, et. al. from 2009, with normal glucose concentrations leading to 
HAEC alignment and elongation with flow, and high glucose concentrations destroying 
that effect. After multiple failed attempts at duplication of the flow setup created by 
Brower and Kelso, this was an important step forward in the study.  
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 The use of fibronectin as the culture substrate for cells exposed to flow did not 
produce a significantly different effect on elongation, relative to cells cultured at normal 
glucose conditions on a gelatin substrate, but it did reduce the degree of cellular 
alignment with the direction of flow. Brower found that cells cultured on fibronectin 
show increased integrin expression, leading to tighter cellular binding to the substrate 
(Brower, 2009). This increased binding may explain the comparatively lower degree of 
cellular alignment in response to flow. 
While the deposits of fibronectin in areas with vascular lesions or atherosclerotic 
plaques may be related to disease states, it does not appear that the fibronectin itself is 
responsible (or can be responsible) for the failure to align and elongate that may be 
associated with the propagation of these lesions. Brower explored the possibility that the 
modulation of cell shear response was due to the presence of advanced glycation end 
products (AGEs), which impaired the function of heparin sulfate proteoglycan, a 
transmembrane protein that may have been involved in the mechanotransduction of fluid 
shear stress (Brower, 2010).  It would appear that fibronectin alone does not have this 
same effect on heparin sulfate proteoglycan, or any other transmembrane protein, cell 
surface receptor, or other signaling pathway. This is consistent with the proliferative 
behavior of cells bound to fibronectin under various circumstances (Schwarts, 2001). 
Fibronectin deposition may not be part of the problem, as it were, but part of the attempt 
at a solution by encouraging the growth of new endothelial cells to cover the lesion. This 
finding should be duplicated if possible, and cell shear response to high glucose while 
cultured on fibronectin may also be tested to determine if fibronectin has any benefits to 
cells already damaged by AGEs. 
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 That the palmitic acid would also fail to modulate the HAEC shear response is 
logical in context of the Brower AGE finding. While high concentrations of saturated free 
fatty acids may lead to a variety of health concerns, they would not necessarily be able to 
act along the same pathways as glucose, in terms of the ability to glycosylate membrane-
bound or membrane-associated proteins and produce the AGEs that appear to impair the 
shear response. Whether the palmitic acid may have a synergistic effect with glucose 
concentrations is unclear. Future studies should examine the possibility that the presence 
of palmitic acid may otherwise cause endothelial cells to be more susceptible to the 
effects of AGEs, such that a lower concentration of glucose may impair the shear 
response if palmitic acid is also present. This is especially relevant given the high 
incidence of diabetics with high triglycerides (Triglycerides, 2011).  
 NO production in endothelial cells cultured under high glucose is significantly 
increased relative to production under normal glucose conditions; production under high 
glucose + aminoguanidine is significantly greater than that of just normal glucose, but 
less than that of high glucose alone. The disparity in expression, especially between 
normal and high glucose conditions, is more indicative of the quantities of NO produced 
by eNOS and iNOS , respectively, since iNOS is known to produce 1000-fold more than 
eNOS9. The literature suggests that eNOS is the primary NO synthetase of endothelial 
cells, and that iNOS is primarily found with macrophages; however, several studies 
indicate that endothelial cells also produce inducible NO (Fukumura, 2006 and Jens 
Kroll, 1998). It would then appear that the normal glucose conditions led the HAECs to 
produce only what is typical of eNOS, while the high glucose conditions resulted in the 
activation of iNOS and the production of significantly greater amounts of nitric oxide. 
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Some possible explanations for this phenomenon include increased vascular stiffness 
with high glucose, resulting in increased NO production to relax smooth muscle tissue, or 
the more probable NO production as part of an inflammatory response.  
 The reduction of cellular NO production in the presence of aminoguanidine, but 
lack of restoration to the levels seen in normal glucose controls, is unexpected, and the 
cause of this phenomenon is unclear. One possible explanation is that there may have 
been insufficient aminoguanidine concentrations to completely reduce NO expression 
back to the levels seen in normal glucose cultures. Aminoguanidine was added at the 
same concentration used to rescue the effects of advanced glycation end products, but 
these may not necessarily be the cause of the induced NO production. It is known, 
however, that aminoguanidine is an inhibitor of both eNOS and iNOS (Fukumura, 2006 
and Jens Kroll, 1998). With sufficiently high concentrations, it is possible that 
aminoguanidine would shut down all NO production. These tests should be reproduced 
with increased concentrations of aminoguanidine to see if this is the case. Additionally, 
the question of whether it is the AGEs, or another effect of the high glucose 
concentrations causing the increased NO production, may be addressed by culturing cells 
with glycosylated bovine serum albumin, a known AGE, and then testing NO production.  
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CHAPTER 3 
ENGINEERING THE EX VIVO MICROENVIRONMENT 
Introduction 
In the previous chapter, the behavior of endothelial cells in the in vitro 
environment was explored, but the value of studying endothelial cell behavior in an ex 
vivo environment is clear when the costs –both time and money—of bringing treatments 
to market is considered. Studying cells in tissue may reveal interactions and behaviors 
that are not elicited in the in vitro environment.  
 The Ex Vivo Endothelial Microenvironment. Endothelial cells in tissue exhibit 
adverse responses when subjected to diabetic conditions: Previous studies have shown 
substantial changes in the morphology of vascular endothelial cells in diabetic models of 
both rabbits and mice (Haddock, 1991 and Yanga, 2001). These changes include 
hyperplasia and cell blebbing, along with a general thickening of the tunica intima 
(Haddock, 1991 and Yanga, 2001). Based on the endothelial alignment and elongation 
behaviors found by Brower (2009), it is hypothesized in this study that the endothelial 
cells of a diabetic model rat will show a failure to respond to in vivo shear stress. A 
subsequent aim of this thesis is then to explore in vivo endothelial alignment and 
elongation for diabetic model rats, through the use of ex vivo imaging of vascular 
endothelial tissue from diabetic models.   
Experimental Constraints in the use of Human Tissue to Study Endothelial Cell 
Behavior. Physicians and researchers at the Phoenix Veteran’s Affairs hospital have 
developed techniques to recover human microvessels from fat biopsies, and to mount and 
pressurize these vessels for use in testing whole-vessel response to stimuli such as nitric 
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oxide. The experimental apparatus used to maintain these vessels during the course of 
hours-long experiments requires extensive volumes, relative to the size of the 
microvessels themselves: 100 mL each of perfusate and superfusate are required for 
vessels that are typically a centimeter or less in length, and no more than 150 microns in 
diameter. Reagents used in these experiments are frequently individually costly, and are 
often intended for use with volumes that are smaller by an order of magnitude or more. 
To facilitate more cost-effective research, one aim of this thesis is to engineer an 
appropriate re-fit of the microvessel apparatus to accommodate a reduction of volume 
while maintaining or improving performance.  
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Figure 3.1: Microvessel Imaging System at the Phoenix Veteran’s Affairs Hospital. 
The chamber marked at A contains the glass cannulae mounts for the microvessel , as 
well as a chamber in which the microvessel sits, and tubing connections to either end of 
the cannulae (where the perfusate enters), and to the chamber (where the superfusate 
enters). In B, the pump and heat exchange apparatus that supply warmth to the 
superfusate require 100mL of volume in the tubing and pump reservoirs. The tubing 
marked at C contains the perfusate, and is connected on either end to 100-mL syringes 
(not shown), partially filled and held at an appropriate height to maintain a 60 mmHg 
pressure within the microvessel.  	  
Methods 
Vessel Explant and Imaging. High-fat diet (HFD) model diabetic rat aortas are 
explanted post-mortem and fixed with 2% para-formaldehyde in phosphate-buffered 
saline, then permeabilized with fixing solution plus 1% Triton-X100 detergent. ZO-1 
polyclonal antibody (Invitrogen #617300, rabbit) is used to detect the outer membrane of 
individual cells via the ZO-1 antigen. Aortas are also stained with ToPro3 for DNA 
detection. Images are acquired using FITC confocal microscopy.  
Microvessel Chamber Engineering Re-Fit. Following discussions with the 
researchers at the Phoenix VA Hospital, regarding the requirements for their experiments, 
and the ideal function of an improved microvessel chamber, design specifications were 
established. Idea generation and selection then occurred, with special effort paid to 
incurring minimal cost while maintaining or improving functionality. Following the 
review and selection of a final design, components were acquired and the re-fit 
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assembled, followed with delivery to the Phoenix VA researchers for their validation and 
use.   
 
Results 
 Rat Model Aortic Endothelial Cell Characterization. Following incubation with 
the ZO-1 polyclonal antibody and ToPro3, images were acquired of the inner luminal 
space of the rat aorta, including the endothelial lining of the vessel. Analysis of cell 
alignment and elongation was not conducted as the bounds of individual cells are not 
clearly defined.  
 
Figure 3.2: Characterization of Rat Aortic Endothelial Cells.  Green 488-nm 
excitation shows the ZO-1 antibody binding sites indicating the boundaries of cells. Blue 
ToPro3 excitation identifies the nuclei of individual cells. In 3.2A (left), the 10x image 
reveals thousands of cells arranged in the endothelial layer. In 3.2B (right), 
approximately two dozen endothelial cells are visualized at the vessel luminal surface.  
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 Microvessel Chamber Re-Fit. The volume of the superfusate system is reduced to 
3 mL, and the volume of the perfusate system is reduced to 500uL. The two 100-ml 
syringes previously required to maintain 60 mmHg pressure are replaced with a 1-mL 
syringe on the leading end of the vessel tubing, and a 5 psi (272 mmHg) pressure gauge. 
Depressing the syringe manually or with a syringe pump can achieve the desired 60 
mmHg (1.1psi) pressure with as few as 500uL in the syringe. The microvessel chamber 
for superfusate is sealed off, and the heat exchanger for the superfusate is re-purposed to 
heat the chamber itself, taking advantage of internal channels that were previously 
unused. Adequate superfusate aeration is ensured through air bubbling via a 20-gauge 
needle connected to an in-house air tank; hemoglobin may be added as necessary to 
increase oxygen tension.  
  
 
 
Figure 3.3: Microvessel Chamber Re-Fit for Phoenix VA Hospital.  A single syringe 
(A) replaces one of two 100-ml reservoirs to provide pressure to the interior of the 
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microvessel. The chamber where the microvessel is mounted, and the superfusate 
surrounds the vessel, is shown in B. In C, a fluid pressure gauge replaces the other 100-
mL reservoir. The gauge is rated to 5 psi, or ~272 mmHg. Brass fittings provide 
compatibility with the small tubing diameter of perfusate system. A needle hookup at D 
provides aeration of the superfusate, and the internal channels indicated at E are 
connected to the previous heat exchange system, warming the superfusate without 
passing the superfusate itself through the 100 mL of tubing. 
 
Discussion 
 
 Rat Aorta Endothelial Cell Characterization. The explanted aortas from the 
diabetic rat model provide an opportunity to begin to characterize endothelial cell 
behavior at a broader level, in the context of the surrounding cell types and tissues. The 
extraction from a recently deceased animal allows close study of physiologic phenomena, 
and may permit future studies to explore the cellular-level findings discussed in the 
previous chapter of this thesis.  
 The results of the imaging of the aorta thus far provide a framework for the 
development of techniques to successfully image the interior of the aorta. Phalloidin, 
which will detect actin within a cell, may be able to provide a clearer representation of 
the boundaries of cells. This in turn would allow the same kinds of alignment and 
elongation analyses that are performed in vitro in this thesis, to also be performed on the 
ex vivo aortas.  
The images acquired to date do not permit this analysis because individual cell 
boundaries are not clearly defined, though the nuclei of individual cells are. To the 
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author’s best knowledge, no one in the literature has applied the ZO-1 antibody to a 
vessel, rather than cells, and this technique may require additional time to permeabilize 
and incubate. An alternative to antibody incubation would be the use of transgenic mice 
with an endothelium that expresses, as an example, green fluorescent protein (GFP).  
Microvessel Chamber Re-Fit. The newly refitted microvessel chamber meets the 
design specifications for the VA researchers and permits substantially reduced quantities 
of reagents to be used to conduct human tissue explant experiments. Total perfusate 
volume is reduced from 100mL to 500uL (a factor of 200) and total superfusate volume 
is reduced from 100 ml to 3mL (a factor of 33). Aeration and heat are kept constant. The 
use of a syringe in combination with a syringe pump opens up the possibility of 
conducting flow experiments, by using a valve at the pressure gauge to allow fluid to drip 
out of the system. Commercially-available microvessel chambers with similar 
specifications cost upwards of $1200; total cost to re-fit this chamber was $87.  
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CHAPTER 4 
 
CONCLUSIONS 
Modulations of the endothelial microenvironment can result in affected cellular 
response to stimuli. This study replicates the findings of Brower, et. al. showing that 
hyperglycemia impairs the endothelial cell shear response. Change of culture substrate 
from gelatin to fibronectin does not affect HAEC elongation response, though it does 
reduce alignment relative to culture under normal glucose on gelatin. Culture with high 
concentrations of palmitic acid, a saturated free fatty acid, does not affect the shear stress 
response. Nitric oxide production is increased in HAECs cultured under high glucose 
conditions, which may indicate the presence of inducible nitric oxide as part of an 
inflammatory response. NO production is reduced, but not restored to levels found in 
normal glucose controls, when HAECs are cultured under high glucose with 
aminoguanidine. Thus, the modulations in microenvironment did induce differences in 
cellular response, especially with respect to hyperglycemia and cellular NO production.  
Explants of vascular tissue, both animal and human, provide the opportunity to 
study cellular behavior at the tissue level. A microvessel chamber is successfully re-
engineered to meet the requirements of reduced volumes while maintaining an equal level 
of functionality and a low cost. An imaging framework for rat aortas is established that 
leads to the ability to test ex vivo endothelial response to diabetic and high fatty acid 
conditions.  
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CHAPTER 5 
 
FUTURE WORK 
Palmitic Acid, High Glucose, and the Buildup of Atherosclerotic Plaques. An 
important long-term aim of this study is to explore the potential link between endothelial 
cell response and the build-up of atherosclerotic plaques. It is hypothesized that the 
failure to align and elongate with the direction of flow leads to the buildup of plaques by 
providing more cross-sectional surface area for the adsorption of LDL cholesterol, and by 
preventing the formation of tight junctions that might otherwise prevent LDL cholesterol 
from reaching the basal side of the endothelium.  
In the studies conducted by Brower and Kelso, the impairment of the alignment 
and elongation response of in vitro HAECs was most pronounced at levels of high 
glucose concentrations (30.5mM). These concentrations are generally higher than the 
day-to-day glucose levels of a majority of diabetics, including those who are being 
treated. Yet, atherosclerotic buildups are still seen. One hypothesis to further explore is 
that free fatty acids may have a “synergistic” effect with high glucose concentrations in 
impairing the alignment and elongation response. Free fatty acids may absorb into the 
lipid membranes of endothelial cells, providing points of inflexibility and overall 
contributing to increased cellular stiffness. Cells, once stiffened, may then be more 
susceptible to a failure to align and elongate once exposed to levels of glucose that are 
heightened relative to normal, but are not at such an extreme as 30.5 mM glucose.  
Aortic Endothelial Alignment and Elongation Ex Vivo. Both the rat aortic diabetic 
model and the human microvessel models provide an unique opportunity to determine if 
the in vitro alignment and elongation behaviors are also true in animals and people who 
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are diabetic, or who eat high-fat diets, or both. An improved method for imaging 
individual cells – perhaps with phalloidin-based detection of actin – is needed, but the 
acquisition and subsequent imaging of tissue from diabetic rats and humans could support 
or disprove the roles of endothelial cell alignment and elongation in the buildup of 
plaques.  
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APPENDIX A  
PROTOCOL FOR PREPARING FLOW CHAMBERSLIDES 
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Materials & Equipment 
• Gelatin stock (7.94 µg/µL). Bovine.  
• Sodium carbonate/ sodium bicarbonate / sodium azide buffering solution. Prepare 
in stock solutions of 50-100mL.  
- 0.35M NaHCO3 
- 0.15M Na2CO3 
- 0.03M NaN3 
• Glass chamber slides (LabTex® II Chamber Slides #177372) 
• 37°C bath 
• Biosafety cabinet 
 
Gelatin-Coating the Chamber Slides 
1. Warm gelatin aliquot in 37°C bath until homogenous and transparent. Vortex as 
needed.  
2. Warm sodium carbonate/bicarbonate/azide buffering solution to 37°C.  
3. In a sterilized biosafety cabinet, pipette gelatin and sodium 
carbonate/bicarbonate/azide solution into 15-mL tubes according to the following 
proportions:  
 
Number of 
Chamber 
Slides to 
Treat 
Quantity of 
Gelatin (µL) 
Quantity of 
buffering 
solution 
(mL) 
Total 
Volume 
(mL) 
1 7.141 2 2.007141 
2 14.282 4 4.014282 
3 21.423 6 6.021423 
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4 28.564 8 8.028564 
5 35.705 10 10.035705 
6 42.846 12 12.042846 
7 49.987 14 14.049987 
8 57.128 16 16.057128 
9 64.269 18 18.064269 
10 71.41 20 20.07141 
*These proportions result in a surface gelatin concentration of 
each chamber slide of 6 µg per square centimeter.  
4. Working quickly, vortex or invert capped centrifuge tube to 
homogenously mix contents.  
5. Pipette 2mL of combined and mixed solution into each chamber 
slide.  
6. Seal chamber slides with Parrafin film.  
7. Rock 4 hours to overnight.  
8. If not to be used within 24 hours, refrigerate at 4°C. Do not keep for 
more than 7 days, even if refrigerated.  
 
Plating Cells onto Chamber Slides 
1. When you are ready to plate cells directly into the chamber slides 
(e.g. you have already counted and re-suspended your cells), remove 
any Parrafin film and open sterilized chamber slides in a sterilized 
biosafety cabinet.  
2. Using suction (such as a Pasteur pipette with vacuum), remove the 
buffering solution from the chamberslide via the side wall of the 
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chamber slide. Do not directly suction the bottom of the chamber 
slide, as this will remove the gelatin coating.  
3. Rinse the chamber slide once with pre-warmed, 37°C, sterile 
phosphate-buffered saline (PBS).  
4. Plate cells at a concentration of 150,000 – 200,000 cells per 
chamber slide. Cells plated at this density will typically reach 
confluence within three to four days. If possible, add cells drop-wise 
and evenly across the surface of the chamber slide.  
5. Gently rock the chamber slide back-and-forth and side-to-side to aid 
even cell spacing.  
6. Replace chamber slide cover. Place chamber slide in one-half of a 
Petri dish if desired for ease of transport. Incubate under desired 
conditions.  
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APPENDIX B 
PROTOCOL FOR FLOW STUDIES 
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Materials & Equipment 
• 25mL of HAEC flow media 
o Normal HAEC media with 10mM HEPES Buffer 
• 1M stock of HEPES Buffer 
• 50mL of 1M Phosphate-buffered saline (PBS) 
• Flow system 
o Peristaltic pump 
o Flow cell capable of fitting a standard microscope slide 
o Flow dampener 
o Vacuum (house vacuum acceptable) 
o Tubing, 1/16” inner diameter. Silastic™ acceptable.  
o Incubator or 37°C room 
• Modifying reagents, as desired (e.g. glucose, palmitate, etc.) 
• Paper towels; 10% bleach.  
 
Preparing the Flow System 
1. Pre-warm the flow system, PBS, and HAEC flow media to 37°C. 
2. Connect flow system with blank microscope slide, begin flow, and flush system 
with 25 mL of PBS. Flow may be adjusted for rapid exchange of PBS. Ensure that 
the flow system does not run dry by continuously adding PBS at the input point.  
3. Exchange flow media for PBS. Drip PBS into waste container; add media in 
segments of 3-5 mL. Once drip waste becomes the color of media, flush 
additional 3-5mL out of the system.  
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4. Check the flow system for the presence of bubbles. Gently tap them along the 
direction of flow to the outlet point.   
5. Cover inlet with aluminum foil as necessary.  
 
Preparing the Cells for Flow 
1. Ensure that cells have reached minimum 80% confluence before staring a flow 
experiment. Desired modifying reagents (glucose, etc.) should be added a 
sufficient incubation period in advance of conducting a flow experiment.  
2. Collect images of the cells on the slide at 10x magnification, ensuring that the 
major axis of the slide is parallel to the bottom horizontal of the image.  
3. Carefully remove the chamber from the chamber slide, using the push-tong device 
provided by LabTek (see Appendix A). Do not allow slide to become dry; add 
pre-warmed media dropwise as necessary.   
 
Starting the Flow Experiment  
1. Stop flow. 
2. Raise flow cell to a level slightly below the inlet.  
3. Break the vacuum.  
4. Allow media from the inlet reservoir to flood into the space on top of the flow 
cell. Ensure that this area is completely wet.  
5. Invert microscope slide such that the cell surface faces the media pool on top of 
the flow cell. 
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6. Firmly press the microscope slide against the wet surface of the flow cell, taking 
care to not introduce any air bubbles to the system.  
7. Connect the vacuum. Ensure a clean seal.  
8. Begin flow at the appropriate volumetric flow rate (e.g. 3.5 ml/min).  
9. Allow flow experiment to run min. 12 hours, max. 16 hours.   
 
Ending Flow Experiment 
 
1. Have a petri dish with pre-warmed media available.  
2. Stop flow (record the time).  
3. Break the vacuum.  
4. Quickly remove the microscope slide and place in the petri dish with pre-warmed 
media.  
5. Quickly ensure that media from the flow system is directed towards the waste 
container as it drains.  
6. Quickly begin collecting images of the microscope slide. Make note of the 
direction of flow, and keep the major axis of the slide parallel with the bottom of 
the image.  
7. After images have been collected, dispose of the microscope slide in appropriate 
waste container.  
8. Flush flow system with PBS; store in PBS.  
9. Sterilize surfaces and properly dispose of any cell-contacted media.  
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APPENDIX C 
PROTOCOL FOR IMAGING EXPLANTED RAT AORTAS 
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Materials and Equipment 
• Fixation Media 
o 2% para-formaldehyde in PBS 
• Permeabilization Media 
o 2% para-formaldehyde in PBS 
o 1% Tween or Triton-X 
• Antibody Wash 
o 45 mL DI/purified water 
o 4.5 mL 10x PBS 
o 0.45g Bovine Serum Albumin (BSA) 
• Phosphate-buffered saline 
• Forceps / tweezers 
• 6-well plates; centrifuge tubes 
 
 
Procedure 
1. Immediately rinse explanted vessel in ice-cold PBS. 2-3 washes, or until PBS is 
clear post-wash. 
2. Fix explanted vessel in fixation media for 30 min. 
3. Transfer explanted vessel to permeabilization media for 30 min.  
4. Wash 3x in antibody wash; 6-well plate or centrifuge tubes may be used.  
5. Dilute primary antibody in antibody wash (typically 1:250, but follow 
manufacturer’s specifications). 
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6. Incubate explanted vessel in primary antibody / antibody wash 8 hours to 
overnight at 4°C.  
7. Wash 3x with antibody wash.  
8. Dilute secondary antibody in antibody wash (typically 1:500). Protect from light.  
9. Incubate vessel in secondary antibody/antibody wash minimum 1 hour at room 
temperature, to overnight at 4°C. Protect from light 
10. Wash 3x PBS.  
11. Add DAPI or ToPro3 as desired for DNA labeling; incubate 15 min at room 
temperature.  
12. Wash 1x PBS.  
13. Mount vessel on microscope slide with vectashield.  
14. Image using appropriate laser excitation.  
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